Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Embryo Adoption Programme of Institut Marquès: Women Come to Spain to Adopt Embryos


News provided by

Institut Marquès

31 May, 2017, 13:32 GMT

Share this article

Share toX

Share this article

Share toX

BARCELONA, Spain, May 31, 2017 /PRNewswire/ --

The baby number 1000 was born thanks to the programme of Institut Marquès  

This image opens in the lightbox
Institut Marques Embryo Adoption (PRNewsfoto/Institut Marques)

The number of international adoptions of children decreases while the number of international adoptions of embryos increases 

Institut Marquès Barcelona launched the embryo adoption in 2004 to give a chance at life to frozen embryos 

Institut Marquès presents the 1000th birth of its international embryo adoption programme. It is a baby girl called Georgina who, with 3,500 kg. of weight, was born in the town of Essex (UK) last February. Her mother decided to adopt an embryo at Institut Marquès, a clinic in Barcelona, after having performed several cycles of assisted reproduction without success in different centres. In June, an embryo that had been frozen for years was transferred; it came from the treatment of a couple who did not answer about the destination they wanted for their embryos and they were thus left under the custody of the clinic.

To view the Multimedia News Release, please click:  

https://www.multivu.com/players/uk/8112351-institut-marques-women-spain-adopt-embryos/

Kerry Andersen, Georgina's mother, is a midwife. A 45-year-old single woman who believes that this treatment has given her "the best of my life, which was the hope of being a mother. I am thrilled to think that my precious daughter is here thanks to the embryo adoption programme as I feel it is a very special way to enjoy motherhood. When I got to know this program, I did not hesitate to adopt an embryo".

Institut Marquès was pioneer in the world launching this initiative in 2004. Embryos that are not transferred remain under the custody of the clinic when the parents do not want to decide on their destination. Therefore, this centre of Barcelona decided to offer them in adoption to its patients. In accordance with Spanish law, the embryos available under this programme come from healthy parents, under the age of 35, who have successfully undergone an In-Vitro-Fertilisation treatment and who no longer want to have more children. During the 12-year life of the programme, patients from 124 different nationalities attended the Institut Marquès' centres. It is the clinic with the highest number of embryo adoptions performed across the world. At the moment, 117 women are expecting a baby thanks to this programme.

Dr. Marisa López-Teijón, Director of Institut Marquès, explains that "the adoption of embryos was launched in 2004 to give the embryos frozen in our centre a possibility to live. From the beginning, the response has been exciting because of the social acceptance, the support offered by different groups and the enthusiasm with which women from all over the world come to us to adopt them. There are less international adoptions of children and more international adoptions of embryos. Behind each case, there is a special story, either of many failures in previous treatments or having given up the possibility of being parents".

Double abandonment 

Embryos that can be adopted come from patients who do not answer the different letters that the clinic sends over a period of four years to choose their destination. After this time, according to the Spanish law, if the couple does not answer, the embryos are placed under the custody of the centre and it is up to the latter to decide about their destination.

Despite offering all possible options, 50% of people with frozen embryos do not answer. 37% choose to keep them; 5% want them to be destroyed; 4%, to be donated to other couples; and 4%, to research.

Many patients do not answer because, in many cases, the decision raises a difficult situation that triggers emotional conflicts. The result is that many embryos remain in the clinics, which very often do not take a decision either and, hence, the embryos suffer a new abandonment.

How do frozen embryos live?

The destination the patients choose for their embryos, according to the country where they come from 

According to data gathered by Institut Marquès, taking into account the country where patients come from, the Germans are the most responsible deciding on the future of their embryos (63.6%) and those who practically do not contemplate the option of destroying them or donating them for research.

However, 63% of French and 60% of UK patients prefer not to decide on the fate of their embryos. In Italy, 45% do not answer and they are the ones that more often opt for conservation (43%). Spaniards do not usually donate their embryos to other couples, only 3% do so, but they are the ones that more frequently donate their embryos for research (6%). Finally, 45% of Irish patients keep their frozen embryos for themselves and they are the ones who donate the most to other couples with 7%.

Adopters' profile 

According to a study carried out by Institut Marquès, 72% of patients who request embryo adoption do so due to sterility problems (ovarian aging, severe male infertility or previous failures in reproduction techniques). They are couples who have unsuccessfully tried other treatments, with an average of more than 4 years wishing to have a baby and with 4.4 failed attempts. 61% had already given up any treatment and the idea of becoming parents

18% of the adopters are women without a male partner who wish to be mothers and another 10% are people who go directly to the adoption of embryos because they do not consider other sterility treatments for ethical or religious reasons.

A third of all these patients had initiated administrative formalities to adopt a child.

Assignment, treatment and success rate 

At Institut Marquès, embryos are assigned through a computer system that ensures that each child is born in a different country than the other embryos resulting from the same treatment. This avoids future consanguinities. Adopters accept that the only parameter to choose their embryo is the race.

Medical treatment for embryo adoption is simple and painless. The woman's uterus is prepared to receive the embryos through estrogen patches and vaginal progesterone tablets. After a few days, the uterus is ready and the embryos are thawed and transferred, requiring no hospitalization. After 14 days, the pregnancy test is performed and, from there on, it evolves like a normal gestation.

Embryo adoption does not require any formal adoption procedure, but only to sign an informed consent where the woman or couple explicitly acknowledge to have been informed about the process and to agree with it.

Throughout these 12 years, the rate of embryonic survival after thawing has been improved thanks to vitrification. The number of embryos transferred has been reduced from an average of 2.2 to 1.3. The global pregnancy average rate was 43% per cycle, which has also been improving every year. Since 2013, it is higher than 50% per cycle.

About Institut Marquès 

Institut Marquès is a clinic of international reference in Gynaecology, Obstetrics and Assisted Reproduction with centres in Barcelona, Milan, London and Ireland (Dublin and Clane).

The clinic, with great experience in cases that present special difficulty, helps people from more than 50 countries achieve their dream of having a baby. Institut Marquès offers the highest success rates of pregnancy, with 89% with their egg donation programme.

Leader in innovation, this centre develops an important line of research on the benefits of music in early life and foetal stimulation.

More information on http://www.institutomarques.com and http://www.institutmarques.ie

Institut Marquès +34-93-285-82-16    

Mireia Folguera: mireia.folguera@institutomarques.com    +34-649-901-494

Estefanía Redondo: estefania.redondo@institutomarques.com   +34-661208385

Footage and press releases in French and German: http://distribucion.europapress.net/InstitutMarques

     (Photo: http://mma.prnewswire.com/media/517863/Embryo_Adoption.jpg )

Video: 
     https://www.multivu.com/players/uk/8112351-institut-marques-women-spain-adopt-embryos/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.